ActivBiotics Pharma Report issue

For profit Phase 2 Phase 3
Founded: Atlanta GA United States (2008)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2008
NCT00251849
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ActivBiotics

Active Ingredients

Drugs in Phase 3 Trials (1)

rifalazil (3 trials)

Drugs in Phase 2 Trials (2)

Key: ActivBiotics Pharma (1) Acquired (1)

azithromycin (zithromax) (1 trial)

m40403 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebrovascular Disorders (Phase 2)

Chlamydia Infections (Phase 2)

Communicable Diseases (Phase 2)

Coronary Artery Disease (Phase 2)

Infections (Phase 2)

Intermittent Claudication (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Vascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3